https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Cosentyx-TM-receives-positive-CHMP-opinion-for-first-line-treatment-of-moderate-to-sever-19432293/?utm_source=telegram&utm_medium=social&utm_campaign=share